NCT06596330

Brief Summary

Type 2 diabetes (T2D) is one of the most common and fastest growing diseases, affecting 1 in 8 adults (nearly 800 million) worldwide by 2045. Sedentary behavior and increased adiposity are major risk factors for T2D. Cardiovascular disease is the leading cause of death in those with T2D, while diabetic microvascular disease, causing kidney disease, neuropathy, and retinopathy, contributes to T2D morbidity. Physical activity is one of the most potent therapies in preventing/treating T2D and its complications. Mean daily steps is a proxy for physical activity, with even modest improvements in step count (i.e., +500 steps) associated with decreased T2D and mortality. However, adherence to regular physical activity remains low in T2D patients, with short-term decreases in daily step count associated with impaired glycemic control and T2D recurrence. The investigators have developed an artificial intelligence (AI) language model (similar to ChatGPT), which can automatically generate coaching prompts to encourage physical activity by incorporating an individual's stage of change. The investigators will extend our research using the My Heart Counts (MHC) smartphone app to 1) validate the efficacy of the AI-generated prompts in patients with T2D and 2) perform a longer-term randomized crossover trial using the language model as a social accountability chatbot - encouraging participants to maintain their physical activity changes over months. The investigators hypothesize that my AI-assisted coaching prompts will significantly increase 1) mean daily step count by 500 steps in 1,000 adults recruited nationwide over a 7-day period, and 2) improve HbA1c and weight via long-term behavior change over a 24-week intervention period.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
37mo left

Started Jul 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jul 2025Jul 2029

First Submitted

Initial submission to the registry

August 26, 2024

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

September 19, 2024

Status Verified

August 1, 2024

Enrollment Period

4 years

First QC Date

August 26, 2024

Last Update Submit

September 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean daily steps

    Mean daily steps over the course of an intervention week (aim 1) and 24 week period (aim 2).

    7 days and 24 weeks

Secondary Outcomes (3)

  • Change in weight

    24 Weeks

  • Change in HbA1c

    24 Weeks

  • Weekly Active Minutes

    7 days and 24 Weeks

Study Arms (2)

LLM-generated coaching prompt

EXPERIMENTAL
Behavioral: Validation of language model prompts in increasing short-term physical activityBehavioral: Assessment of long-term changes to physical activity and glycemic control

10,000 Step Reminder

ACTIVE COMPARATOR
Behavioral: Validation of language model prompts in increasing short-term physical activityBehavioral: Assessment of long-term changes to physical activity and glycemic control

Interventions

Aim 1: In preliminary data, the investigators have pre-trained an open-source language model, LLAMA, with expert-created coaching prompts based on the stages of change model for physical activity. Seven different prompts (for each day of an intervention "week") will be generated, accounting for race/ethnicity, age, gender, and stage of change, to improve personalization. Using the existing MHC app, the investigators will perform a randomized crossover trial on mean daily steps across each intervention. The investigators will compare the interventions of a daily reminder to reach 10,000 steps (a neutral control) and AI-personalized interventions based on an individual's stage of change.

10,000 Step ReminderLLM-generated coaching prompt

Aim 2: Using social accountability and the trained language model generating personalized coaching interventions, the investigators will conduct a long-term follow-up randomized, unblinded trial. Over a 24-week intervention period, participants will receive either a generic daily reminder to reach 10,000 steps or an AI-generated coaching prompt, with the AI group also being able to "chat" with the language model to ask for advice on maintaining their physical activity. The outcomes of this long-term trial will be change in: 1) daily steps over the intervention period, 2) weight (via HealthKit link to MHC), and 3) HbA1c (as derived from EMR records linked to the HIPAA-compliant MHC app).

10,000 Step ReminderLLM-generated coaching prompt

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged ≥18 years old, with a clinical diagnosis of T2D, able to read and understand English, and who are physically able to walk, will be included in our study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Glycemic Control

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Dan Kim, MD, PhD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fellow in Medicine

Study Record Dates

First Submitted

August 26, 2024

First Posted

September 19, 2024

Study Start

July 1, 2025

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

July 1, 2029

Last Updated

September 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share